Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice
Intervertebral disc degeneration is a leading cause of chronic back pain and disability. Here the authors show that long term treatment with senolytic compounds Dasatinib and Quercetin reduces disc senescence burden and ameliorates age-dependent degeneration in mice.
Guardado en:
Autores principales: | Emanuel J. Novais, Victoria A. Tran, Shira N. Johnston, Kayla R. Darris, Alex J. Roupas, Garrett A. Sessions, Irving M. Shapiro, Brian O. Diekman, Makarand V. Risbud |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e824b98a87ac47fa8c57f62f8e079e2c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Stem cell horizons in intervertebral disc degeneration
por: Joseph Ciacci, et al.
Publicado: (2009) -
Senolytic effects of quercetin in an in vitro model of pre-adipocytes and adipocytes induced senescence
por: Elena Zoico, et al.
Publicado: (2021) -
The Effects of Elgucare on Degenerated Intervertebral Disc-Induced Low Back Pain and Disc Regeneration: A Clinical Trial
por: Wen-Cheng Lo, et al.
Publicado: (2021) -
Preclinical development of a microRNA-based therapy for intervertebral disc degeneration
por: Ming-liang Ji, et al.
Publicado: (2018) -
(-)-Epigallocatechin-3-gallate Ameliorates Intervertebral Disc Degeneration Through Reprogramming of the Circadian Clock
por: Liangwei Mei, et al.
Publicado: (2021)